AKL 1 Asthma Study
NCT00407524
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Asthma
Interventions
DRUG:
AKL 1
Sponsor
University of Aberdeen